References
-
1
Rubins J B, Dunits J, Rubins H B, Maddaus M A, Niewoehner D E.
Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer.
J Thorac Cardiovasc Surg.
1998;
116
412-416
-
2
NIH .
Carcinoembryonic antigen: its role as a marker in the management of cancer.
BMJ.
1981;
282
373-375
-
3
Niklinski J, Furman M, Laudanski J, Kozlowski M.
Prognostic value of pretreatment CEA, SCC-Ag and CA19-9 levels in sera of patients with non-small cell lung cancer.
Eur J Cancer Prev.
1992;
1
401-406
-
4
Icard P, Regnard J F, Essomba A, Panebianco V, Magdeleinat P, Levasseur P.
Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer.
Ann Thorac Surg.
1994;
58
811-814
-
5
Graziano S L, Tatum A H, Newman N B. et al .
The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.
Cancer Res.
1994;
54
2908-2913
MD Hiroaki Satoh
Division of Respiratory Medicine, Institute of Clinical Medicine, University of Tsukuba
Tsukuba-City
Ibaraki, 305-8575
Japan
Phone: +81 (298) 53-3210
Fax: +81 (298) 53-3320
Email: hirosato@md.tsukuba.ac.jp
